Halozyme Therapeutics
HALO
#2490
Rank
HK$45.24 B
Marketcap
HK$355.61
Share price
-0.13%
Change (1 day)
17.33%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$12.95 Billion

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are HK$12.95 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$12.88 B-1.37%
2022-12-31HK$13.06 B84.59%
2021-12-31HK$7.07 B112.83%
2020-12-31HK$3.32 B-9.96%
2019-12-31HK$3.69 B146.4%
2018-12-31HK$1.49 B-38.44%
2017-12-31HK$2.43 B6.78%
2016-12-31HK$2.27 B111.93%
2015-12-31HK$1.07 B11.28%
2014-12-31HK$0.96 B2.36%
2013-12-31HK$0.94 B41.87%
2012-12-31HK$0.66 B56.22%
2011-12-31HK$0.42 B-22.88%
2010-12-31HK$0.55 B1.44%
2009-12-31HK$0.54 B15.2%
2008-12-31HK$0.47 B32.71%
2007-12-31HK$0.35 B99.07%
2006-12-31HK$0.17 B902.09%
2005-12-31HK$17.85 M45.5%
2004-12-31HK$12.27 M479.1%
2003-12-31HK$2.11 M-55.46%
2002-12-31HK$4.75 M18453.07%
2001-12-31HK$0.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$5.21 B-59.79%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$476.89 B 3,580.12%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$144.76 B 1,017.14%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$987.61 B 7,521.19%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$473.45 B 3,553.55%๐Ÿ‡ซ๐Ÿ‡ท France
HK$841.40 B 6,392.95%๐Ÿ‡บ๐Ÿ‡ธ USA